JMJD2A and JMJD3 were reported to regulate cardiac hypertrophy by epigenetically targeting FHL1 and MHC promoter, respectively (Zhang et al., 2011; Guo et al., 2018). The gene discussed is HLA-C; the disease is cardiac hypertrophy.